XML 54 R36.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
GOODWILL AND INTANGIBLE ASSETS (Tables)
12 Months Ended
Mar. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
(In thousands)PlasmaBlood CenterHospitalTotal
Carrying amount as of April 2, 2022$29,043 $34,166 $404,078 $467,287 
Currency translation— (311)(745)(1,056)
Carrying amount as of April 1, 202329,043 33,855 403,333 466,231 
Acquisitions— — 87,079 87,079 
Purchase accounting adjustments— — 12,283 12,283 
Currency translation— (371)(140)(511)
Carrying amount as of March 30, 2024$29,043 $33,484 $502,555 $565,082 
Schedule of Amoritized Intangibles
The gross carrying amount of intangible assets and the related accumulated amortization as of March 30, 2024 and April 1, 2023 is as follows:
(In thousands)Gross Carrying
Amount
Accumulated
Amortization
Net
As of March 30, 2024  
Amortizable:
Developed technology$464,291 $178,413 $285,878 
Customer contracts and related relationships255,144 190,033 65,111 
Capitalized software84,837 69,491 15,346 
Patents and other24,504 11,820 12,684 
Trade names14,320 5,456 8,864 
Total$843,096 $455,213 $387,883 
Non-amortizable:
In-process research and development$13,667 
In-process software development4,567 
Total$18,234 
(In thousands)Gross Carrying
Amount
Accumulated
Amortization
Net
As of April 1, 2023  
Amortizable:
Developed technology$362,506 $153,099 $209,407 
Customer contracts and related relationships203,240 187,774 15,466 
Capitalized software78,962 60,776 18,186 
Patents and other18,504 10,831 7,673 
Trade names9,508 4,942 4,566 
Total$672,720 $417,422 $255,298 
Non-amortizable:
In-process research and development$13,667 
In-process software development3,841 
In-process patents2,965 
Total$20,473 
Schedule of Future Amortization Expense
Amortization expense on intangible assets for the next five years is estimated to be as follows:
(In thousands)
Fiscal 2025$44,016 
Fiscal 2026$37,407 
Fiscal 2027$35,228 
Fiscal 2028$33,456 
Fiscal 2029$32,378